Skip to main content

Advertisement

We’d like to understand how you use our websites in order to improve them. Register your interest.

Retraction Note: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women

Retraction

This article [1] has been retracted by the editors of BMC Research Notes because, contrary to the statement in the manuscript, Moi University Institutional Research and Ethics Committee (IREC) has confirmed that ethics approval was not obtained to conduct this study. In addition, the authors did not have permission to use data from the DREAM program.

References

  1. 1.

    Ngemu EK, Khayeka–Wandabwa C, Kweka EJ, Choge JK, Anino E, Oyoo-Okoth E: Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women. BMC Res Notes. 2014, 7: 52-10.1186/1756-0500-7-52.

    PubMed  PubMed Central  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Eliningaya J Kweka.

Additional information

The online version of the original article can be found at 10.1186/1756-0500-7-52

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ngemu, E.K., Khayeka–Wandabwa, C., Kweka, E.J. et al. Retraction Note: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women. BMC Res Notes 7, 868 (2014). https://doi.org/10.1186/1756-0500-7-868

Download citation